Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics exploit these vulnerabilities.
Benzimidazoles: Disruption of Microtubule Function Benzimidazoles such as albendazole, mebendazole, thiabendazole, and triclabendazole are broad-spectrum agents that impair tubulin polymerization. This inhibition compromises parasite motility, energy metabolism, and reproductive processes. Their efficacy spans intestinal nematodes (e.g., Ascaris, Trichuris), cestodes (e.g., Taenia, Echinococcus), and certain flukes (e.g., Fasciola). Albendazole additionally exhibits activity against Giardia and is a key component in mass drug administration strategies for filariasis.
Neuromuscular Blockers: Tetrahydropyrimidines and Piperazines
Pyrantel pamoate, a tetrahydropyrimidine, induces depolarization of nematode muscle cells by activating cholinergic receptors, leading to paralysis and expulsion. Diethylcarbamazine (DEC), a piperazine derivative immobilizes microfilariae through poorly defined mechanisms, including altered arachidonic acid metabolism and enhanced host immune clearance. DEC is crucial in filariasis treatment and is increasingly used in single-dose regimens.
Ion Channel Modulators and Calcium Agonists Ivermectin, an avermectin, targets chloride channels, causing hyperpolarization and paralysis. It is effective against intestinal nematodes and filariae, notably reducing microfilarial loads in onchocerciasis. Praziquantel, a pyrazinoisoquinoline, acts as a calcium agonist, increasing intracellular Ca2+ in trematodes and cestodes, which leads to muscular contraction and tegument disruption, exposing antigens to host immune responses.
Mitochondrial Disruptors and Secondary Agents Niclosamide, a phenolic compound, uncouples oxidative phosphorylation in cestodes, depleting ATP stores and immobilizing the parasite. Other secondary agents, including oxamniquine, metrifonate, and suramin, are used selectively for specific trematode and filarial infections.
This targeted diversity in mechanism highlights the complexity of helminth biology and underscores the necessity for tailored anthelmintic strategies.
Anthelmintic agents are drugs that eliminate parasitic helminths, often targeting adult forms, though some affect larval or egg stages.
For example, pyrazinoisoquinoline drugs, such as praziquantel, target the protective tegumental cells of the parasite.
Praziquantel enters these cells and triggers a rapid influx of calcium ions through ion channels.
The sudden calcium entry results in sustained muscle contraction. Eventually, the parasite becomes paralyzed in the contracted state.
This disruption makes the tegument porous, exposing inner surfaces and internal antigens to the host immune system.
These morphological changes weaken the parasite's defenses, making it more susceptible to immune attack.
As a result, immune modulators, such as antibodies, can act on the exposed parasite antigens, enhancing host immune recognition.
This immune response acts synergistically with praziquantel, accelerating the clearance of the parasite.
繁體中文
